Shuttle Pharmaceuticals (Nasdaq: SHPH) to Ring Nasdaq Opening Bell on Wednesday, January 18, 2023Rockville, MD and Irvine, CA — January 18, 2022 – Boustead Securities, LLC (“Boustead”) client Shuttle Pharmaceuticals Holdings, Inc....
VisionThree (V3) is Reimagining the Recruiting Industry with Virtual RealityIrvine, CA – November 22, 2022 - Boustead Securities' client VisionThree (V3) is an immersive experience software service & content...
Shuttle Pharmaceuticals (Nasdaq: SHPH) Enters into Manufacturing Agreement for RopidoxuridineRockville, MD and Irvine, CA — September 22, 2022 – Boustead Securities, LLC (“Boustead”) client Shuttle Pharmaceuticals Holdings, Inc....
Boustead IPO Client Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test KitLondon & Irvine, CA, September 21, 2022 – Boustead Securities, LLC (Boustead) client Virax Biolabs ("Virax" or the "Company") (Nasdaq:...
Know Labs, Inc. Announces Closing of $8.28 Million Public Offering of Common StockIrvine, CA — September 20, 2022 – Boustead Securities, LLC (“Boustead”) client Know Labs, Inc. (NYSE: KNW), an emerging developer of...